Lip W. Lee
Wilmslow Rd
Manchester, ENG, United Kingdom
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 23, 2026
Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland.
Journal: Oral oncology
Published: December 05, 2025
Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.
Journal: Physics and imaging in radiation oncology
Published: November 28, 2025
Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer - Quality of life results from the phase III ARTFORCE trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 22, 2025
Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 09, 2024
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).
Journal: International journal of radiation oncology, biology, physics
Published: October 30, 2023
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer.
Journal: Oral oncology
Published: July 24, 2023
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Journal: Clinical and translational radiation oncology
Published: October 17, 2022
Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117].
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 12, 2022
Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
Journal: International journal of radiation oncology, biology, physics
Published: September 13, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 06, 2022
Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy.
Journal: The British journal of radiology
Published: February 28, 2022
Last Updated: 09/26/2026